Status:
TERMINATED
Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
Lead Sponsor:
Mannkind Corporation
Conditions:
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to evaluate pulmonary function test (PFT) sub-study in interested subjects from studies MKC-TI-161, MKC-TI-162 and MKC-TI-166. 100 Type I and 100 Type II diabetics will be...
Detailed Description
This study is designed to evaluate and compare changes in pulmonary function (FEV1(forced expiratory volume in 1 second) FVC(forced vital capacity), TLC (total lung capacity) and DLco) in subjects enr...
Eligibility Criteria
Inclusion
- Enrollment in one of three parent trials (MKC-TI-161, MKC-TI-162 or MKC-TI-166)
Exclusion
- Subjects who are unable to perform PFTs that meet American Thoracic Society/European Respiratory Society (ATS/ERS) quality recommendations for acceptability and repeatability will be excluded from this study
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01201928
Start Date
October 1 2010
End Date
March 1 2012
Last Update
December 6 2012
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Valley Research
Fresno, California, United States, 93720
2
Health Care Partners Medical Group
Long Beach, California, United States, 90806
3
Laureate Clinical Research Group
Atlanta, Georgia, United States, 30308
4
Atlanta Diabetes Associates
Atlanta, Georgia, United States, 30309